Welcome Shonan Health Innovation Park (iPark) to Twins´ International MultiHelix (TIM)

On May 14th 2019 a Partnership Agreement was signed between Shonan Health Innovation Park (iPark), Japan and Twins´ International MultiHelix (TIM). It is our pleasure to welcome iPark as an International Network member and to start collaborating in the field of Life Sciences to create value for people´s health and wellbeing. The strategic focus areas of iPark are Regenerative Medicine, Rare Diseases, Dementia and Disease Prevention. This creates an excellent fit with other international members of TIM. The ambition of iPark is to build a Life Science ecosystem that is open to the world where public, private and academic sectors come together to propel and transform innovative ideas into patient benefit. iPark is representing the seventh country in TIM´s membership portfolio and the first country from Asia.

Shonan Health Innovation Park (iPark) began operations in April 2018, with the aim of creating a co-location ecosystem comprised of researchers, industry experts, venture startups, government, and academia who will collaborate and co-create - to accelerate research, with the aim of transforming cutting-edge science into impactful health solutions for patients across the world.

Takeda launched Shonan iPark by transforming its Shonan research site to enhance scientific innovation with the aspiration to become a world-class ecosystem. Shonan iPark is supported by the local government and aligns well with the backbone of the government’s economic and revitalization strategy.

iPark will be represented by Dr Toshio Fujimoto, General Manager, in the TIM Annual Meeting this year held in Lund on 9th-10th of Sept. Please take the opportunity to interact with Dr Fujimoto and find out more about iPark and how you could start a collaboration.

Read more about iPark at https://www.shonan-health-innovation-park.com/en/